Edy Kornelius1, Jeng-Yuan Chiou1, Yi-Sun Yang1, Chiung-Huei Peng1, Yung-Rung Lai1, Chien-Ning Huang1. 1. Institute of Medicine (E.K., Y.-S.Y., C.-N.H.), Chung Shan Medical University, Taichung 402, Taiwan; Chung Shan Medical University Hospital (E.K., Y.-S.Y., C.-N.H.), Department of Internal Medicine, Division of Endocrinology and Metabolism, Taichung 402, Taiwan; School of Health Policy and Management (J.-Y.C.), Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan; Division of Basic Medical Research (C.-H.P.), Hung Kuang University, Taichung 433, Taiwan; and Chung Shan Medical University Hospital Pharmacy (Y.-R.L.), Taichung 402, Taiwan.
Abstract
CONTEXT: The risks of thyroid dysfunction after iodinated contrast media (ICM) exposure are largely unknown, especially in Asian populations. OBJECTIVE: The objective was to determine whether ICM exposure in patients with normal thyroid would increase the risk of thyroid dysfunction, including hyperthyroidism or hypothyroidism. DESIGN: This was a retrospective cohort study including a random selection of 1 million people in 2005. SETTING: General population of Taiwan was studied. PATIENTS: Patients with ICM exposure were identified as cases, whereas patients without any ICM exposure were selected as controls. INTERVENTION: Interventions included ICM exposure or nonexposure in normal thyroid function patients. MAIN OUTCOME: The primary endpoint was the composite risk of thyroid dysfunction associated with ICM exposure. RESULTS: A total of 19 642 cases and 78 568 matched controls were recruited in this study. The mean ages of ICM exposure and nonexposure were 53.9 and 53.6 years, respectively, and mean follow-up durations were 4.1 and 5.6 years, respectively. After adjustment, patients with ICM exposure had a significantly higher risk of thyroid dysfunction (hazard ratio, 1.46; 95% confidence interval [CI], 1.29-1.66). In the subgroup analysis, the adjusted hazard ratios of hyperthyroidism and hypothyroidism compared with controls were 1.22 (95% CI, 1.04-1.44) and 2.00 (95% CI, 1.65-2.44), respectively. CONCLUSIONS: ICM exposure was associated with higher risk of thyroid dysfunction, including hyperthyroidism and hypothyroidism.
CONTEXT: The risks of thyroid dysfunction after iodinated contrast media (ICM) exposure are largely unknown, especially in Asian populations. OBJECTIVE: The objective was to determine whether ICM exposure in patients with normal thyroid would increase the risk of thyroid dysfunction, including hyperthyroidism or hypothyroidism. DESIGN: This was a retrospective cohort study including a random selection of 1 million people in 2005. SETTING: General population of Taiwan was studied. PATIENTS: Patients with ICM exposure were identified as cases, whereas patients without any ICM exposure were selected as controls. INTERVENTION: Interventions included ICM exposure or nonexposure in normal thyroid function patients. MAIN OUTCOME: The primary endpoint was the composite risk of thyroid dysfunction associated with ICM exposure. RESULTS: A total of 19 642 cases and 78 568 matched controls were recruited in this study. The mean ages of ICM exposure and nonexposure were 53.9 and 53.6 years, respectively, and mean follow-up durations were 4.1 and 5.6 years, respectively. After adjustment, patients with ICM exposure had a significantly higher risk of thyroid dysfunction (hazard ratio, 1.46; 95% confidence interval [CI], 1.29-1.66). In the subgroup analysis, the adjusted hazard ratios of hyperthyroidism and hypothyroidism compared with controls were 1.22 (95% CI, 1.04-1.44) and 2.00 (95% CI, 1.65-2.44), respectively. CONCLUSIONS: ICM exposure was associated with higher risk of thyroid dysfunction, including hyperthyroidism and hypothyroidism.
Authors: Çağın Mustafa Üreyen; Kahraman Coşansu; Mustafa Gökhan Vural; Sait Emir Şahin; Mehmet Akif Çakar; Harun Kılıç; Mustafa Tarık Ağaç; Hüseyin Gündüz; Ramazan Akdemir; Ersan Tatlı Journal: Med Princ Pract Date: 2019-09-20 Impact factor: 1.927
Authors: Meaghan L Barr; Harvey K Chiu; Ning Li; Michael W Yeh; Connie M Rhee; Jacqueline Casillas; Paul J Iskander; Angela M Leung Journal: J Clin Endocrinol Metab Date: 2016-03-28 Impact factor: 5.958
Authors: Vidhu V Thaker; Marjorie F Galler; Audrey C Marshall; Melvin C Almodovar; Ho-Wen Hsu; Christopher J Addis; Henry A Feldman; Rosalind S Brown; Bat-Sheva Levine Journal: J Endocr Soc Date: 2017-07-11